Human clinical PAH features were observed in pulmonary endothelial-specific conditional BMPR2 knockout mice [3], SMC-specific BMPR2 dominant-negative mice [4,5], and BMPR2 heterozygous mutant rats [6]. This evidence concerns the gene BMPR2 and pulmonary arterial hypertension.